High Sierra Technologies, Inc. (HSTI)
USD 1.0
(-9.09%)
USD 1.0
(-9.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 482.04 Thousand USD | -1.38% |
| 2021 | 488.8 Thousand USD | 8.91% |
| 2020 | 448.8 Thousand USD | 16.71% |
| 2019 | 384.55 Thousand USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 175.19 Thousand USD | -30.16% |
| 2016 | 250.85 Thousand USD | 65.72% |
| 2015 | 151.36 Thousand USD | -7.39% |
| 2014 | 163.44 Thousand USD | 18.59% |
| 2013 | 137.82 Thousand USD | 1252854.55% |
| 2012 | 11.00 USD | -80.36% |
| 2011 | 56.00 USD | -99.93% |
| 2010 | 80 Thousand USD | 33.33% |
| 2009 | 60 Thousand USD | 0.0% |
| 2008 | 60 Thousand USD | 20.0% |
| 2007 | 50 Thousand USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | 518.03 Thousand USD | 7.47% |
| 2023 Q3 | 624.31 Thousand USD | 19.49% |
| 2023 Q2 | 522.47 Thousand USD | 0.86% |
| 2022 FY | 482.04 Thousand USD | -1.38% |
| 2022 Q3 | 588.8 Thousand USD | 0.0% |
| 2022 Q2 | 588.8 Thousand USD | 0.0% |
| 2022 Q1 | 588.8 Thousand USD | 20.46% |
| 2022 Q4 | 482.04 Thousand USD | -18.13% |
| 2021 Q2 | 488.8 Thousand USD | 8.91% |
| 2021 Q3 | 488.8 Thousand USD | 0.0% |
| 2021 Q4 | 488.8 Thousand USD | 0.0% |
| 2021 FY | 488.8 Thousand USD | 8.91% |
| 2021 Q1 | 448.8 Thousand USD | 0.0% |
| 2020 Q3 | 413.3 Thousand USD | 5.29% |
| 2020 FY | 448.8 Thousand USD | 16.71% |
| 2020 Q1 | 387.15 Thousand USD | 0.68% |
| 2020 Q2 | 392.55 Thousand USD | 1.39% |
| 2020 Q4 | 448.8 Thousand USD | 8.59% |
| 2019 Q4 | 384.55 Thousand USD | 8.16% |
| 2019 Q2 | 50 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | 355.55 Thousand USD | 611.11% |
| 2019 FY | 384.55 Thousand USD | 0.0% |
| 2018 Q1 | 291.81 Thousand USD | 2.25% |
| 2018 Q4 | - USD | -100.0% |
| 2018 FY | - USD | -100.0% |
| 2018 Q2 | 816.43 Thousand USD | 179.78% |
| 2018 Q3 | 508.07 Thousand USD | -37.77% |
| 2017 Q3 | 279.11 Thousand USD | 2.4% |
| 2017 FY | 175.19 Thousand USD | -30.16% |
| 2017 Q1 | 266.09 Thousand USD | 6.08% |
| 2017 Q4 | 285.38 Thousand USD | 2.25% |
| 2017 Q2 | 272.57 Thousand USD | 2.43% |
| 2016 Q3 | 243.12 Thousand USD | 4.23% |
| 2016 Q4 | 250.85 Thousand USD | 3.18% |
| 2016 FY | 250.85 Thousand USD | 65.72% |
| 2016 Q2 | 233.26 Thousand USD | 3.23% |
| 2016 Q1 | 225.96 Thousand USD | 4.12% |
| 2015 Q4 | 217.02 Thousand USD | 3.88% |
| 2015 Q1 | 183.29 Thousand USD | 12.14% |
| 2015 FY | 151.36 Thousand USD | -7.39% |
| 2015 Q2 | 198.56 Thousand USD | 8.33% |
| 2015 Q3 | 208.91 Thousand USD | 5.21% |
| 2014 Q3 | 155.86 Thousand USD | 4.87% |
| 2014 Q4 | 163.44 Thousand USD | 4.86% |
| 2014 Q1 | 145.46 Thousand USD | 5.54% |
| 2014 Q2 | 148.63 Thousand USD | 2.18% |
| 2014 FY | 163.44 Thousand USD | 18.59% |
| 2013 Q1 | 682.00 USD | 6100.0% |
| 2013 FY | 137.82 Thousand USD | 1252854.55% |
| 2013 Q4 | 137.82 Thousand USD | 1.74% |
| 2013 Q3 | 135.46 Thousand USD | 8.57% |
| 2013 Q2 | 124.77 Thousand USD | 18195.01% |
| 2012 Q4 | 11.00 USD | -99.99% |
| 2012 Q3 | 110 Thousand USD | 10.0% |
| 2012 Q2 | 100 Thousand USD | 2039.5% |
| 2012 FY | 11.00 USD | -80.36% |
| 2012 Q1 | 4674.00 USD | 8246.43% |
| 2011 FY | 56.00 USD | -99.93% |
| 2011 Q4 | 56.00 USD | -99.94% |
| 2011 Q3 | 90 Thousand USD | 12.5% |
| 2011 Q2 | 80 Thousand USD | 1608.67% |
| 2011 Q1 | 4682.00 USD | -94.15% |
| 2010 Q1 | 70 Thousand USD | 16.67% |
| 2010 Q4 | 80 Thousand USD | 14.29% |
| 2010 Q3 | 70 Thousand USD | 0.0% |
| 2010 FY | 80 Thousand USD | 33.33% |
| 2010 Q2 | 70 Thousand USD | 0.0% |
| 2009 Q3 | 60 Thousand USD | 0.0% |
| 2009 FY | 60 Thousand USD | 0.0% |
| 2009 Q4 | 60 Thousand USD | 0.0% |
| 2009 Q1 | 60 Thousand USD | 6.67% |
| 2009 Q2 | 60 Thousand USD | 0.0% |
| 2008 Q4 | 56.24 Thousand USD | 0.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 2467.00 USD | 0.0% |
| 2008 FY | 60 Thousand USD | 20.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | 50 Thousand USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.85 Million USD | 73.969% |
| BioQuest Corp. | 183.3 Thousand USD | -162.981% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | 76.902% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 99.228% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| GSRX Industries Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |